-
Inovio Subcontractor Hits Back With Lawsuit Against Coronavirus Vaccine Developer
Friday, July 10, 2020 - 9:48am | 487Read More...Inovio Pharmaceuticals Inc (NASDAQ: INO) could be embroiled in a prolonged legal battle with its Blue Bell, Pennsylvania-headquartered subcontractor VGXI, Inc, after the subcontractor sued the pharma company. The Inovio Lawsuit: VGXI filed a lawsuit this week in the Montgomery County...
-
Moderna Strikes Another Coronavirus Vaccine Manufacturing Deal To Ensure Overseas Supply
Thursday, July 9, 2020 - 9:42am | 473Read More...Moderna Inc (NASDAQ: MRNA) announced another manufacturing deal Thursday for mRNA-1273, its vaccine candidate for the novel coronavirus. Moderna Covering All Manufacturing Bases: The Boston, Massachusetts-based company said Thursday it has entered into a collaboration with Laboratorios Farmac...
-
Novavax CEO Talks $1.6B Federal Funding Win, Ex-FDA Chief Says It's A 'Good Bet'
Tuesday, July 7, 2020 - 11:48am | 466Read More...The U.S. government awarded Novavax, Inc. (NASDAQ: NVAX) $1.6 billion in funding to support its COVID-19 vaccine, and the company is confident it has the capability to produce 100 million doses by the end of the year, Novavax CEO Stanley Erck said on CNBC's "Squawk Box." Novavax...
-
Novavax Shares Cross $100 Threshold On $1.6B Federal Funding Award For Coronavirus Vaccine
Tuesday, July 7, 2020 - 8:59am | 458Read More...Novavax, Inc. (NASDAQ: NVAX) shares, which were up about 1,900% year-to-date, are seeing further strength after the company's coronavirus vaccine program was shortlisted by the U.S. government's Operation Warp Speed and awarded $1.6 billion in federal funding. Novavax Joins...
-
Revisiting Coronavirus Vaccine Timelines: Moderna Denies Delay, Pfizer Advances Project Lightspeed And More
Monday, July 6, 2020 - 2:42pm | 806Read More...Shares of Moderna Inc (NASDAQ: MRNA), a frontrunner in the race for a coronavirus vaccine, tumbled Thursday afternoon after a STAT News report suggested there could be a delay in the initiation of a late-stage study. Moderna's July Start In Doubt: Moderna's Phase 3 trial of...
-
PreMarket Prep Stock Of The Day: Pfizer
Sunday, July 5, 2020 - 2:58pm | 795Read More...Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session. On any given...
-
Pfizer, BioNTech Report Promising Initial Data From Coronavirus Vaccine Study
Wednesday, July 1, 2020 - 1:21pm | 487Read More...Pfizer Inc. (NYSE: PFE), which is one of the five companies shortlisted by the U.S. government's Operation Warp Speed coronavirus vaccine program, reported positive preliminary data Wednesday. The readiout is from the Phase 1/2 study of the mRNA vaccine against coronavirus that Pfizer...
-
Cramer Welcomes 3 Stocks To His COVID-19 Index, Kicks Out 3 Others
Tuesday, June 30, 2020 - 12:02pm | 424Read More...CNBC "Mad Money" host Jim Cramer has been managing a mock index of 100 stocks that stand to benefit financially from the coronavirus pandemic. On Monday, Cramer replaced three names in his index meant to help investors get better exposure to the stay-at-home-economy. What's Out:...
-
Inovio Plunges On Interim Phase 1 Coronavirus Data; DNA Vaccine Shows 94% Response Rate
Tuesday, June 30, 2020 - 10:44am | 496Read More...Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were moving to the downside Tuesday after the vaccine maker released interim Phase 1 data for the study that is evaluating its DNA vaccine INO-4800 against SARS-CoV-2, the virus that causes COVID-19. Inovio's Interim Phase 1 Efficacy,...
-
Vaxart Rallies On Double Dose Of Positive Coronavirus Vaccine Developments
Friday, June 26, 2020 - 9:25am | 515Read More...Shares of oral vaccine maker Vaxart Inc (NASDAQ: VXRT) are on a strong two-day run after two announcements tied to coronavirus vaccine development. What Happened: The South San Francisco, California-based company said its oral COVID-19 vaccine has been selected to participate in a non-human...
-
Moderna Closing In On Deal To Supply Coronavirus Vaccine To Israel: Report
Monday, June 15, 2020 - 12:42pm | 304Read More...Moderna Inc (NASDAQ: MRNA) reportedly is close to signing a coronavirus vaccine deal with Israel, a testament to the validity and viability of the company's vaccine program. What Happened: The vaccine deal, which is reportedly in advanced stages of discussion, was reported by Israeli news...
-
Early Coronavirus Vaccines Likely To Target Further Complications, Not Infection, Health Experts Say
Monday, June 15, 2020 - 9:08am | 511Read More...Some of the earliest novel coronavirus (COVID-19) vaccines to be approved are more likely to target prevention against developing severe symptoms from catching the virus, rather than the initial infection, multiple health experts told Bloomberg. What Happened Imperial College London professor Robin...
-
Sinovac Makes Headway In Coronavirus Vaccine Race With Positive Preliminary Phase 1/2 Results
Monday, June 15, 2020 - 8:55am | 430Read More...Chinese biopharma Sinovac Biotech, which is one of 10 companies doing human testing of a vaccine candidate for SARS-CoV-2, the virus that causes COVID-19, announced positive preliminary data Monday from Phase 1/2 clinical trials. What Happened: The company said its vaccine candidate...
-
AstraZeneca Strikes Deal With Four EU Countries Over 400M Coronavirus Vaccine Doses
Monday, June 15, 2020 - 8:32am | 327Read More...AstraZeneca plc (NYSE: AZN) on Saturday said it had reached an agreement with Europe's Inclusive Vaccines Alliance (IVA) to supply 400 million doses of its novel coronavirus (COVID-19) vaccines by the end of the year. What Happened The IVA is a group of four countries, Germany, France, the...
-
Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July
Thursday, June 11, 2020 - 12:16am | 409Read More...Johnson & Johnson (NYSE: JNJ) will begin the human clinical trials of its novel coronavirus (COVID-19) vaccine in July, the company announced Wednesday. What Happened The human trials of the Johnson & Johnson COVID-19 vaccine were earlier expected to begin in September. The pharmaceutical...
